Navigation Links
BioProcess International December 2012 Issue Now Available on the App Store for iPad and iPhone

New York, NY (PRWEB) December 27, 2012

BioProcess International (BPI) announces the publication of the December 2012 issue of BioProcess International on the App Store for iPad and iPhone. With this issue, BPI begins a new annual theme focusing on management and executive issues and brings back elements from the BioExecutive International publication. Also published on the App Store for December is an exclusive 48 page supplement covering Flexible Manufacturing.

The December Issue of BioProcess International includes the following articles:

Rapid Pharmaceutical Product Development: Getting Off the Critical Path and Onto the Right Path

A Framework for Process Knowledge Management: Reducing Risk and Realizing Value from Development to Manufacturing (Part 1 — Conceptual Framework)

Managing Cost Without Sacrificing Quality

A Decade of Success: The BPI Awards Honor Upstream, Downstream, and Manufacturing Achievements Over the Past 10 Years

Encouraging In-House Disclosures in a Whistleblower’s World

Understanding the Patient Journey: A Human-Factors Road Map to Delivery Device Development

Where’s the Viral Marketing for Spreading Info on Actual Viruses?

The Flexible Manufacturing Supplement includes the following articles:

Multiproduct Facility Design and Control for Biologics

Safety, Flexibility, and Efficiency: Preparing for the Future in Filling

Efficient Flexible Facilities for the 21st Century

Developing an Integrated, Continuous Bioprocessing Platform

Toward Flexible Hybrid Facilities of the Future

Establishing Strategic Supplier Partnerships to Facilitate Manufacturing Flexibility

Lean Six Sigma: A CMO’s Most Useful Traveling Companion

Biopharmaceuticals on Demand: Free from Traditional Restraints, China Reinvents Biomanufacturing

Download the BioProcess International mobile app by searching the app store for “BioProcess International” or visiting

About BioProcess International

BioProcess International™ ( is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process.

BioProcess International™ is part of the IBC Life Sciences Division of Informa, plc, a leading international provider of specialist information and services for the academic, professional and business communities. Informa offers a world-class portfolio of publications, events and data services for researchers, students, lecturers and professionals in the academic and scientific communities worldwide.

Subscribe today at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioStorage Technologies Expands its Service Offering to Include Advanced Bioprocessing Solutions
2. UV Flu Technologies Expands Its International Footprint
3. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
4. International Attendance for Networking and Education at Informex Beyond Manufacturing
5. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
6. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
7. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
8. PAREXEL International to Present at J.P. Morgan Healthcare Conference
9. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform:
10. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
11. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
Post Your Comments:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality ... Several trends in analytical testing are being attributed to new regulatory requirements for ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply ... a time. So which eye do you rinse first if a dangerous substance enters both ... Duo Eye Wash with its unique dual eye piece. , “Whether its dirt and ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... SAN DIEGO, CALIF. (PRWEB) , ... October 10, 2017 , ... ... website as part of its corporate rebranding initiative announced today. The bold new ... broaden its reach, as the company moves into a significant growth period. , It ...
Breaking Biology Technology:
(Date:10/4/2017)... a global clinical research organization (CRO), announces the launch of Shadow, ... 2017. Shadow is designed to assist medical writers and biometrics teams ... European Medicines Agency (EMA) in meeting the requirements for de-identifying clinical ... ... Tom ...
(Date:6/23/2017)... N.Y. and ITHACA, N.Y. ... ) and Cornell University, a leader in dairy research, ... with bioinformatics designed to help reduce the chances that ... With the onset of this dairy project, Cornell University ... Consortium for Sequencing the Food Supply Chain, a food ...
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
Breaking Biology News(10 mins):